Blood pressure in heart failure management and prevention

被引:20
作者
Maeda, Daichi [1 ]
Dotare, Taishi [1 ]
Matsue, Yuya [1 ]
Teramoto, Kanako [2 ,3 ]
Sunayama, Tsutomu [1 ]
Tromp, Jasper [4 ,5 ,6 ,7 ]
Minamino, Tohru [1 ,8 ]
机构
[1] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Biol & Med, Tokyo, Japan
[2] Natl Heart Ctr, Singapore, Singapore
[3] Natl Cerebral & Cardiovasc Ctr, Dept Biostat, Osaka, Japan
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[5] Natl Univ Hlth Syst, Singapore, Singapore
[6] Duke Natl Univ Singapore, Singapore, Singapore
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[8] Japan Agcy Med Res & Dev, Japan Agcy Med Res & Dev Core Res Evolutionary Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
Blood pressure; DASH diet; Heart failure; Hypertension; Pharmacotherapy; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR HYPERTROPHY; LIPID-LOWERING TREATMENT; CONVERTING-ENZYME-INHIBITOR; ASSOCIATION TASK-FORCE; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; WEIGHT-LOSS; ANTIHYPERTENSIVE TREATMENT; AMERICAN-COLLEGE;
D O I
10.1038/s41440-022-01158-x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a leading cause of heart failure and other cardiovascular diseases. Its role in the pathogenesis of heart failure with reduced ejection fraction (HFrEF) differs from that in heart failure with preserved ejection fraction (HFpEF). Moreover, rigorous blood pressure control may reduce the incidence of heart failure. However, once heart failure develops, prognosis is affected by blood pressure, which may differ between patients with and without heart failure. Therefore, the association between guideline-directed medical therapy (GDMT) for heart failure and its uptitration must be considered for blood pressure management and should not be overlooked. Heart failure medications affect the blood pressure and efficacy per baseline blood pressure value. This review discusses the potential mechanisms by which hypertension leads to HFrEF or HFpEF, the impact of hypertension on incident heart failure, and the recommended approaches for blood pressure management in patients with heart failure.
引用
收藏
页码:817 / 833
页数:17
相关论文
共 138 条
[51]   Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis Practitioner-Based Nationwide JAMP Study [J].
Kario, Kazuomi ;
Hoshide, Satoshi ;
Mizuno, Hiroyuki ;
Kabutoya, Tomoyuki ;
Nishizawa, Masafumi ;
Yoshida, Tetsuro ;
Abe, Hideyasu ;
Katsuya, Tomohiro ;
Fujita, Yumiko ;
Okazaki, Osamu ;
Yano, Yuichiro ;
Tomitani, Naoko ;
Kanegae, Hiroshi .
CIRCULATION, 2020, 142 (19) :1810-1820
[52]   Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study [J].
Kario, Kazuomi ;
Okada, Kenta ;
Kato, Mitsutoshi ;
Nishizawa, Masafumi ;
Yoshida, Tetsuro ;
Asano, Tsuguyoshi ;
Uchiyama, Kazuaki ;
Niijima, Yawara ;
Katsuya, Tomohiro ;
Urata, Hidenori ;
Osuga, Jun-ichi ;
Fujiwara, Takeshi ;
Yamazaki, Shoji ;
Tomitani, Naoko ;
Kanegae, Hiroshi .
CIRCULATION, 2019, 139 (18) :2089-2097
[53]   Consensus Document on Improving Hypertension Management in Asian Patients, Taking Into Account Asian Characteristics [J].
Kario, Kazuomi ;
Chen, Chen-Huan ;
Park, Sungha ;
Park, Chang-Gyu ;
Hoshide, Satoshi ;
Cheng, Hao-Min ;
Huang, Qi-Fang ;
Wang, Ji-Guang .
HYPERTENSION, 2018, 71 (03) :375-382
[54]   Treatment of high blood pressure and gain in event-free life expectancy [J].
Kassai, Behrouz ;
Boissel, Jean-Pierre ;
Cucherat, Michel ;
Boutitie, Florent ;
Gueyffier, Francois .
VASCULAR HEALTH AND RISK MANAGEMENT, 2005, 1 (02) :163-169
[55]   Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus [J].
Kato, Eri T. ;
Silverman, Michael G. ;
Mosenzon, Ofri ;
Zelniker, Thomas A. ;
Cahn, Avivit ;
Furtado, Remo H. M. ;
Kuder, Julia ;
Murphy, Sabina A. ;
Bhatt, Deepak L. ;
Leiter, Lawrence A. ;
McGuire, Darren K. ;
Wilding, John P. H. ;
Bonaca, Marc P. ;
Ruff, Christian T. ;
Desai, Akshay S. ;
Goto, Shinya ;
Johansson, Peter A. ;
Gause-Nilsson, Ingrid ;
Johanson, Per ;
Langkilde, Anna Maria ;
Raz, Itamar ;
Sabatine, Marc S. ;
Wiviott, Stephen D. .
CIRCULATION, 2019, 139 (22) :2528-2536
[56]   Effects of blood pressure lowering in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis [J].
Kawano, Hiroaki ;
Fujiwara, Akira ;
Kai, Hisashi ;
Kumagai, Eita ;
Okamoto, Ryuji ;
Shibata, Rei ;
Ohtsubo, Toshio ;
Tamura, Kouichi ;
Maemura, Koji ;
Arima, Hisatomi .
HYPERTENSION RESEARCH, 2019, 42 (04) :504-513
[57]   Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes [J].
Khan, Muhammad Shahzeb ;
Felker, G. Michael ;
Pina, Ileana L. ;
Camacho, Alexander ;
Bapat, Devavrat ;
Ibrahim, Nasrien E. ;
Maisel, Alan S. ;
Prescott, Margaret F. ;
Ward, Jonathan H. ;
Solomon, Scott D. ;
Januzzi, James L. ;
Butler, Javed .
JACC-HEART FAILURE, 2021, 9 (02) :137-145
[58]   Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial) [J].
Khan, Nadia A. ;
Rabkin, Simon W. ;
Zhao, Yinshan ;
McAlister, Finlay A. ;
Park, Julie E. ;
Guan, Meijiao ;
Chan, Sammy ;
Humphries, Karin H. .
HYPERTENSION, 2018, 71 (05) :840-+
[59]   Management of hypertension associated with cardiovascular failure [J].
Kiuchi, Shunsuke ;
Ikeda, Takanori .
JOURNAL OF CARDIOLOGY, 2022, 79 (06) :698-702
[60]   Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry [J].
Komajda, Michel ;
Schoepe, Jakob ;
Wagenpfeil, Stefan ;
Tavazzi, Luigi ;
Boehm, Michael ;
Ponikowski, Piotr ;
Anker, Stefan D. ;
Filippatos, Gerasimos S. ;
Cowie, Martin R. .
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) :921-929